logo

For the Inventor, By the Inventor

Boca Raton, FL, United States of America

Charles H Hennekens

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 1999-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles H Hennekens. Retrieved from https://idiyas.com/inventor/charles-h-hennekens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 75.0


Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 151(Granted Patents)


Location History:

  • Wellesley, MA (US) (1999)
  • South Natick, MA (US) (2000)
  • Boca Raton, FL (US) (2006 - 2011)

Company Filing History:

goldMedal4 out of 1,428 
 
The Brigham and Women's Hospital, Inc.
 patents

Years Active: 1999-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 7964614 - Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease (2011-06-21),
2. 7030152 - Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease (2006-04-18),
3. 6040147 - Systemic inflammatory markers as diagnostic tools in the prevention of (2000-03-21),
4. 5871766 - Beta-carotene vitamin E therapy for inhibition of major vascular events (1999-02-16),

Title: Charles H. Hennekens: Innovator in Cardiovascular Health

Introduction

Charles H. Hennekens is a prominent inventor based in Boca Raton, FL (US). He has made significant contributions to the field of cardiovascular health through his innovative research and inventions. With a total of 4 patents, Hennekens has focused on developing diagnostic tools that aid in the prevention and treatment of atherosclerotic diseases.

Latest Patents

Hennekens' latest patents include groundbreaking methods for utilizing systemic inflammatory markers as diagnostic tools. These inventions involve characterizing an individual's risk profile for developing future cardiovascular disorders by measuring levels of systemic inflammation. Additionally, these methods evaluate the likelihood that an individual will benefit from treatment aimed at reducing the risk of future cardiovascular disorders.

Career Highlights

Hennekens has had a distinguished career, contributing to advancements in medical research and innovation. His work has been instrumental in enhancing the understanding of cardiovascular health and the role of inflammation in disease prevention.

Collaborations

Hennekens has collaborated with notable professionals in his field, including Paul M. Ridker. Their joint efforts have furthered research and development in cardiovascular diagnostics and treatment strategies.

Conclusion

Charles H. Hennekens stands out as a key figure in the innovation of cardiovascular health diagnostics. His contributions through patents and collaborations continue to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…